Akero Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Akero Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akero Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Akero Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $4.6M | 200k | 23.00 |
| 2023-09-30 | $5.5M | 108k | 50.50 |
| 2023-03-31 | $5.1M | 134k | 38.26 |
| 2022-12-31 | $4.6M | 83k | 54.80 |
| 2022-09-30 | $77k | 2.2k | 34.88 |
| 2021-12-31 | $1.1M | 50k | 21.15 |
| 2021-03-31 | $1.7M | 60k | 29.01 |
| 2020-12-31 | $113k | 4.4k | 25.89 |
| 2020-09-30 | $101k | 3.3k | 30.74 |
| 2020-06-30 | $193k | 7.7k | 24.95 |
| 2020-03-31 | $99k | 4.7k | 21.14 |
| 2019-12-31 | $71k | 3.2k | 22.28 |
| 2019-09-30 | $4.6k | 211 | 21.74 |